Revisiting 5α-reductase inhibitors and the risk of prostate cancer
Sign Up to like & getrecommendations! Published in 2018 at "Nature Reviews Urology"
DOI: 10.1038/s41585-018-0018-9
Abstract: The role of 5α-reductase inhibitors (5-ARI) in prostate cancer chemoprevention remains a controversy, as cancer prevention trials with 5-ARIs have shown a decreased incidence of low-grade prostate cancer but a potential increased risk in high-grade… read more here.
Keywords: cancer; reductase inhibitors; prostate cancer; revisiting reductase ... See more keywords